Literature DB >> 27923605

Rhodomyrtone inhibits lipase production, biofilm formation, and disorganizes established biofilm in Propionibacterium acnes.

Suttiwan Wunnoo1, Jongkon Saising2, Supayang Piyawan Voravuthikunchai3.   

Abstract

Virulence enzymes and biofilm a play crucial role in the pathogenesis of Propionibacterium acnes, a major causative agent of acne vulgaris. In the present study, the effects of rhodomyrtone, a pure compound identified from Rhodomyrtus tomentosa (Aiton) Hassk. leaves extract against enzyme production and biofilm formation production by 5 clinical isolates and a reference strain were evaluated. The degree of hydrolysis by both lipase and protease enzymes significantly decreased upon treatment with the compound at 0.125-0.25 μg/mL (p < 0.05). Lipolytic zones significantly reduced in all isolates while decrease in proteolytic activities was found only in 50% of the isolates. Rhodomyrtone at 1/16MIC and 1/8MIC caused significant reduction in biofilm formation of the clinical isolates (p < 0.05). Percentage viability of P. acnes within mature biofilm upon treated with the compound at 4MIC and 8MIC ranged between 40% and 85%. Pronounced properties of rhodomyrtone suggest a path towards developing a novel anti-acne agent.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biofilm; Lipase; Propionibacterium acnes; Rhodomyrtone

Mesh:

Substances:

Year:  2016        PMID: 27923605     DOI: 10.1016/j.anaerobe.2016.12.002

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  9 in total

1.  In vivo safety assessment of rhodomyrtone, a potent compound, from Rhodomyrtus tomentosa leaf extract.

Authors:  Thanyaluck Siriyong; Julalak Chorachoo Ontong; Sukanlaya Leejae; Sakol Suwalak; Peter John Coote; Supayang Piyawan Voravuthikunchai
Journal:  Toxicol Rep       Date:  2020-07-31

Review 2.  The Health Beneficial Properties of Rhodomyrtus tomentosa as Potential Functional Food.

Authors:  Thanh Sang Vo; Dai Hung Ngo
Journal:  Biomolecules       Date:  2019-02-21

3.  Rhodomyrtone as a New Natural Antibiotic Isolated from Rhodomyrtus tomentosa Leaf Extract: A Clinical Application in the Management of Acne Vulgaris.

Authors:  Suttiwan Wunnoo; Siwaporn Bilhman; Thanaporn Amnuaikit; Julalak C Ontong; Sudarshan Singh; Sauvarat Auepemkiate; Supayang P Voravuthikunchai
Journal:  Antibiotics (Basel)       Date:  2021-01-22

4.  Prediction of Antibacterial Peptides against Propionibacterium acnes from the Peptidomes of Achatina fulica Mucus Fractions.

Authors:  Suwapitch Chalongkulasak; Teerasak E-Kobon; Pramote Chumnanpuen
Journal:  Molecules       Date:  2022-03-31       Impact factor: 4.411

5.  Activation of Deoxyribonuclease I by Nicotinamide as a New Strategy to Attenuate Tetracycline-Resistant Biofilms of Cutibacterium acnes.

Authors:  Yi-Hsien Shih; Donald Liu; Yen-Chou Chen; Ming-Hsuan Liao; Woan-Ruoh Lee; Shing-Chuan Shen
Journal:  Pharmaceutics       Date:  2021-05-31       Impact factor: 6.321

6.  The novel antibiotic rhodomyrtone traps membrane proteins in vesicles with increased fluidity.

Authors:  Dennapa Saeloh; Varomyalin Tipmanee; Kin Ki Jim; Marien P Dekker; Wilbert Bitter; Supayang P Voravuthikunchai; Michaela Wenzel; Leendert W Hamoen
Journal:  PLoS Pathog       Date:  2018-02-16       Impact factor: 6.823

Review 7.  Multitarget Approaches against Multiresistant Superbugs.

Authors:  Declan Alan Gray; Michaela Wenzel
Journal:  ACS Infect Dis       Date:  2020-03-19       Impact factor: 5.084

Review 8.  Staphylococcus epidermidis and Cutibacterium acnes: Two Major Sentinels of Skin Microbiota and the Influence of Cosmetics.

Authors:  Mathilde Fournière; Thomas Latire; Djouhar Souak; Marc G J Feuilloley; Gilles Bedoux
Journal:  Microorganisms       Date:  2020-11-07

9.  Rhodomyrtone Accumulates in Bacterial Cell Wall and Cell Membrane and Inhibits the Synthesis of Multiple Cellular Macromolecules in Epidemic Methicillin-Resistant Staphylococcus aureus.

Authors:  Ozioma F Nwabor; Sukanlaya Leejae; Supayang P Voravuthikunchai
Journal:  Antibiotics (Basel)       Date:  2021-05-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.